Tuyet‐Hang Pham - Concepedia

Author

Tuyet‐Hang Pham

AstraZeneca (United States)

Also Known As

T. Pham, T.-H. Pham, T.‐H. Pham, Tuyet-Hang Pham, Tuyet‐Hang Pham

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)Amgen (United States)National Institute of Arthritis and Musculoskeletal and Skin Diseases Altimmune (United States)AstraZeneca (Finland)

About

Tuyet‐Hang Pham is an author at AstraZeneca (United States) specializing in immunology, medicine, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	405
2	Immunology	5	5	405
3	Allergy	2	2	43
4	Allergy Medicine	1	1	15
5	Clinical Immunology	1	1	15

Tuyet‐Hang Pham

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist Ivona Aksentijevich, Seth L. Masters, Polly J. Ferguson, New England Journal of Medicine	2009	977
Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection Jennifer Kearley, Jonathan S. Silver, Caroline Sandén, Immunity InflammationTobacco ControlCytokineInnate Immune SystemImmunology	2015	324
A pilot study to evaluate the safety and efficacy of the long‐acting interleukin‐1 inhibitor rilonacept (interleukin‐1 trap) in patients with familial cold autoinflammatory syndrome Raphaela Goldbach‐Mansky, Sharukh D. Shroff, Mildred Wilson, Arthritis & Rheumatism	2008	228
S100A12 is a novel molecular marker differentiating systemic‐onset juvenile idiopathic arthritis from other causes of fever of unknown origin Helmut Wittkowski, Michael Frosch, Nico Wulffraat, Arthritis & Rheumatism	2008	217
Reductions in eosinophil biomarkers by benralizumab in patients with asthma Tuyet‐Hang Pham, Gautam Damera, Paul Newbold, Respiratory Medicine	2016	180
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus Yuko Shirota, Cheryl Yarboro, Randy Fischer, Annals of the Rheumatic Diseases	2012	122
Baseline type 2 biomarker levels and response to tezepelumab in severe asthma Jonathan Corren, Tuyet‐Hang Pham, Esther García Gil, Allergy	2021	112
Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases Sriram Sridhar, Hao Liu, Tuyet‐Hang Pham, Respiratory Research	2019	65
Airway and serum biochemical correlates of refractory neutrophilic asthma Rafeul Alam, James T. Good, Donald Rollins, Journal of Allergy and Clinical Immunology	2017	62
CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial E. William St. Clair, Alan N. Baer, Wan‐Fai Ng, Nature Medicine	2024	50

Page 1